MedPath

惠州大亚制药股份有限公司

Ownership
-
Established
1992-11-05
Employees
-
Market Cap
-
Website
www.hzdaya.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

91

NMPA:91

Drug Approvals

炎热清颗粒

Approval Number
国药准字Z20090402
Approval Date
Mar 15, 2024
NMPA

Diphenhydramine Hydrochloride Tablets

Product Name
盐酸苯海拉明片
Approval Number
国药准字H44021544
Approval Date
Aug 20, 2020
NMPA

Chloramphenicol Tablets

Product Name
氯霉素片
Approval Number
国药准字H44021539
Approval Date
Aug 20, 2020
NMPA

Nicoyinamide Tablets

Product Name
烟酰胺片
Approval Number
国药准字H44020834
Approval Date
Aug 20, 2020
NMPA

Dexamethasone Acetate Tablets

Product Name
醋酸地塞米松片
Approval Number
国药准字H44020804
Approval Date
Aug 20, 2020
NMPA

Prednisone Acetate Tablets

Product Name
醋酸泼尼松片
Approval Number
国药准字H44020821
Approval Date
Aug 20, 2020
NMPA

Furazolidone Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H44021547
Approval Date
Aug 14, 2020
NMPA

Pyritinol Hydrochloride Tablets

Product Name
盐酸吡硫醇片
Approval Number
国药准字H44021545
Approval Date
Aug 5, 2020
NMPA

Vitamin E Nicotinicate Capsules

Product Name
维生素E烟酸酯胶囊
Approval Number
国药准字H44024590
Approval Date
Aug 5, 2020
NMPA

Compound Bismuth Subnitrate Tablets

Product Name
复方石菖蒲碱式硝酸铋片
Approval Number
国药准字H44024591
Approval Date
Aug 5, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.